Wearables such as smartwatches are already an integral part of our everyday lives. They track our pulse, the number of steps we take and our sleep rhythm. Glucose measurement using CGM systems is currently considered the gold standard. Can Dincer, Professor of Sensors and Wearables for Healthcare at the Technical University of Munich (TUM), explains in an interview in which direction the development can still go in the future.
Publikation
- InFo DIABETOLOGIE & ENDOKRINOLOGIE
Related Topics
You May Also Like
- Deep vein thrombosis
Outpatient or inpatient treatment?
- Sarcoidosis, echinococcosis & Co.
Suspected symptoms and differential diagnoses
- Cancer prevention
Constant dripping – alcohol and cancer
- Steatotic liver disease
GLP-1RA in MASH – what’s new?
- Chronic pruritus: “Tour d'horizon”
Focus on new anti-inflammatory therapeutic approaches
- Multiple sclerosis
Unexpected side effects when switching from natalizumab to a biosimilar
- "Patients W.A.I.T. Indicator"
Access to new drugs is becoming increasingly difficult
- Immunotherapy